Bitcoin Holder MicroStrategy And 4 More Short Squeeze Stocks That Could Soar This Week - PAXMEDICA INC by

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move.

High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze. Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard.

PaxMedica Inc: Clinical stage biopharmaceutical company PaxMedica Inc (NASDAQ:PXMD) is developing treatments for autism spectrum disorder. The company held its IPO in August 2022 with a pricing of $5.25 per share. Fintel data shows 24% of the float short and a cost to borrow of 104.8%. The stock moves up 11 places on the leaderboard for the week.

IBio: Healthcare company IBio (AMEX:IBIO) jumps 33 places on the leaderboard to rank second for the week. Data shows 120.1% of the float short and a cost to borrow of 5.6%. Shares are up over 200% year-to-date, likely leading to an increase in the number of people betting against the company.

MicroStrategy Inc: Software company MicroStrategy Incorporated (NASDAQ:MSTR) rejoins the leaderboard, moving up 12 places. The company, which is also one of the biggest holders of Bitcoin (CRYPTO: BTC) has been a high short-interest stock with an increase in investors betting against the company and also against the leading cryptocurrency. Data shows 35.8% of the float short and a cost to borrow of 29.4% for MicroStrategy. The stock moved up 12 places to rank third for the week.

Greenwich LifeSciences: Clinical stage biopharmaceutical company Greenwich LifeSciences (NASDAQ:GLSI) ranks fourth for the week after topping the leaderboard last week. Data shows 27.9% of the float short, down slightly from last week’s 28.5%. The cost to borrow on shares is 11.3%, up from last week’s 11.1%. The stock has frequently been on the leaderboard in 2022.

Aerovate Therapeutics: Clinical stage biopharmaceutical company Aerovate Therapeutics (NASDAQ:AVTE) slides three places from last week to rank fifth for the week. Data shows 31.5% of the float short, in line with last week’s figure. The cost to borrow on shares is 6.9%, up slightly from last week’s 6.8%.

PXMDPAXMEDICA INC by PaxMedica, Inc.

GLSIGreenwich LifeSciences Inc

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.